Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
26 Setembro 2024 - 9:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to
release its third quarter 2024 financial results after market close
on Thursday, October 24, 2024. Management will hold a conference
call to review the company's third quarter 2024 performance
starting at 4:30 p.m. (Eastern Time) on the same day. The
conference call will be concurrently webcast. The link to the
webcast will be available on the Dexcom investor relations website
at investors.dexcom.com and will be archived there for future
reference.
To listen to the conference call, please dial (877) 344-3040
(US/Canada) or (646) 475-1647 (International) and use the
confirmation ID "9430114" approximately five minutes prior to the
start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of health through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom simplifies and improves
diabetes management around the world. For more information about
Dexcom CGM, visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240926232570/en/
DexCom, Inc.: Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
DexCom (NASDAQ:DXCM)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
